China · Pharmaceuticals startup
China · OnQuality Pharmaceuticals Ltd.
OnQuality Pharmaceuticals Ltd.
Funding reportedLast round: Series A
About OnQuality Pharmaceuticals Ltd.
OnQuality Pharmaceuticals Ltd.
is a pharmaceutical company focused on targeted cancer supportive care. The company develops treatments aimed at alleviating specific side effects caused by cancer therapies, helping patients maintain a better quality of life during their treatment. OnQuality specializes in two main areas: oncodermatology, which addresses skin-related toxicities, and oncogastroenterology, which focuses on gastrointestinal toxicities. Their product pipeline includes OQL011, a topical ointment for Hand-Foot Skin Reaction, and OQL051, a gut-restricted CDK4/6 inhibitor designed to prevent chemotherapy-induced diarrhea. Utilizing an AI-enabled platform, OnQuality designs therapies that target the molecular sources of treatment-related toxicities. The company is headquartered in Seattle, Washington, and has successfully raised $15 million in Series A financing to support its mission.
What company datasets say OnQuality Pharmaceuticals Ltd. raised
Funding, as reported
The company, in detail
What they build
Known for
medicalpharmaceuticalspharmaceutical manufacturing
Built with from their website
Alibaba Cloud MailAlibaba Cloud
- Sector
- Pharmaceuticals
- Industry code
- NAICS 541714, SIC 2834
- Region
- Shanghai Shi
- Revenue
- 3.1M a year, as listed
- Full record
- Every detail in the company directory
Pharmaceuticals in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put OnQuality Pharmaceuticals Ltd. in front of investors. Or tell us what we have wrong.